BEVERLY BAKER-NEWSHOLME: Open Payments
NPI 1649330218 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 16 payments from 10 companies in 2025. Trend: 2023 $259 · 2024 $1,059 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| Lundbeck LLC | 2 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $40 |
| Neurelis, Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| SK Life Science, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: VYEPTI, PONVORY, UBRELVY, VALTOCO, KESIMPTA, INGREZZA, QULIPTA, KISUNLA.
Industry payments across CO — which companies pay providers there.
